We recently published a list of Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against Health Insurance Companies.

In a report released on February 26, John Ivankoe from J.P. Morgan maintained a Hold rating on Texas Roadhouse (TXRH – Research Report), with a ...

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Coupang (CPNG – Research Report), Texas Roadhouse ...

Texas Roadhouse's solid balance sheet, no debt, and increasing franchisees can support its expansion. Learn why TXRH stock is ...

Texas Roadhouse, Inc. (NASDAQ:TXRH) has announced that it will be increasing its dividend from last year's comparable payment on the 1st of April to $0.68. Even though the dividen ...

We came across a bullish thesis on Texas Roadhouse, Inc. (TXRH) on Substack by Summit Stocks. In this article, we will ...

Texas Roadhouse shows strong profitability but faces flat margins and growth challenges. Read why I still see TXRH stock as a ...

Hernan E. Mujica, the CHIEF TECHNOLOGY OFFICER of $TXRH, sold 2,050 shares of the company on 02-24-2025 for an estimated $349,853. We received data on the trade from ...

In this article, we are going to take a look at where Texas Roadhouse, Inc. (NASDAQ:TXRH) stands against other stocks that Jim Cramer Discusses with insights on Trump DOJ’s action against health ...

Texas Roadhouse (NASDAQ:TXRH – Free Report) had its target price trimmed by Stifel Nicolaus from $185.00 to $172.00 in a ...

Texas Roadhouse (NASDAQ:TXRH – Get Free Report) had its price objective dropped by stock analysts at Truist Financial from $209.00 to $205.00 in a research report issued on Friday,Benzinga reports.

Despite ongoing cost pressures, Texas Roadhouse's value-focused approach continues to drive industry-leading traffic growth.